1. Home
  2. LBRDA vs KRYS Comparison

LBRDA vs KRYS Comparison

Compare LBRDA & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Broadband Corporation

LBRDA

Liberty Broadband Corporation

HOLD

Current Price

$51.34

Market Cap

7.3B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$246.89

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRDA
KRYS
Founded
2014
2015
Country
United States
United States
Employees
1900
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
7.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
LBRDA
KRYS
Price
$51.34
$246.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$115.00
$297.60
AVG Volume (30 Days)
153.2K
209.7K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
N/A
6.84
Revenue
N/A
$389,130,000.00
Revenue This Year
N/A
$40.88
Revenue Next Year
$109.28
$35.16
P/E Ratio
$8.39
$36.12
Revenue Growth
N/A
33.94
52 Week Low
$42.05
$123.03
52 Week High
$100.85
$298.30

Technical Indicators

Market Signals
Indicator
LBRDA
KRYS
Relative Strength Index (RSI) 50.69 42.60
Support Level $47.83 $233.64
Resistance Level $55.15 $248.60
Average True Range (ATR) 1.71 8.78
MACD 0.01 -0.26
Stochastic Oscillator 67.59 22.29

Price Performance

Historical Comparison
LBRDA
KRYS

About LBRDA Liberty Broadband Corporation

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: